Cladribine, Low-Dose Cytarabine (LDAC), and Venetoclax (VEN) in Older/Unfit Acute Myeloid Leukemia (AML) Patients: A Single-Institution Experience
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）
Key words
AML, cladribine, low-dose cytarabine, older/unfit AML
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined